In a 20-year-old woman, what do a creatinine of 0.48 mg/dL, alanine aminotransferase of 30 U/L, hemoglobin 11.6 g/dL, mean corpuscular hemoglobin 26.7 pg, and platelet count 437 ×10⁹/L suggest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Findings Suggest Mild Microcytic Anemia with Reactive Thrombocytosis, Most Consistent with Iron Deficiency Anemia

This 20-year-old woman's laboratory values indicate mild microcytic anemia (hemoglobin 11.6 g/dL with low MCH 26.7 pg) accompanied by reactive thrombocytosis (platelet count 437 ×10⁹/L), a pattern highly suggestive of iron deficiency anemia that requires iron studies and investigation of the underlying cause.

Interpretation of Individual Values

Hemoglobin: Mild Anemia

  • Her hemoglobin of 11.6 g/dL falls below the WHO threshold of 12 g/dL for non-pregnant women over 15 years 1, 2
  • This represents mild anemia that warrants investigation, particularly given the microcytic pattern

Mean Corpuscular Hemoglobin: Microcytosis Indicator

  • MCH of 26.7 pg is reduced (normal range typically 27-31 pg)
  • Low MCH indicates microcytic anemia, which typically suggests iron deficiency, thalassemia trait, or chronic disease 2
  • In a young woman, iron deficiency is the most likely etiology

Platelet Count: Reactive Thrombocytosis

  • Platelet count of 437 ×10⁹/L is elevated (normal range approximately 150-400 ×10⁹/L)
  • Thrombocytosis commonly accompanies iron deficiency anemia as a reactive phenomenon
  • The platelet/MCH ratio of 16.4 (437/26.7) exceeds the 12.0 cutoff that suggests combined iron and vitamin B12 deficiency with 74.6% sensitivity 3, though in this young woman, menstrual blood loss makes isolated iron deficiency more probable

ALT: Normal Liver Function

  • ALT of 30 U/L is within normal limits 4
  • This excludes significant hepatic pathology as a contributor to her anemia

Creatinine: Normal Renal Function

  • Creatinine of 0.48 mg/dL is normal for a young woman (mean for US women is 0.96 mg/dL, with lower values common in younger individuals) 5
  • This excludes chronic kidney disease as a cause of anemia

Clinical Significance and Next Steps

Immediate Workup Required

The combination of microcytic anemia and thrombocytosis mandates:

  1. Iron studies (serum ferritin, transferrin saturation, serum iron, TIBC) to confirm iron deficiency 1, 2

    • Ferritin <25 ng/mL in females indicates insufficient iron stores 2
    • Low transferrin saturation confirms inadequate iron availability for erythropoiesis
  2. Assessment for blood loss sources:

    • Detailed menstrual history (most common cause in premenopausal women) 1
    • Gastrointestinal symptoms or occult bleeding evaluation if menstrual losses don't explain severity
    • Dietary assessment for inadequate iron intake

Treatment Approach

Once iron deficiency is confirmed:

  • Oral iron supplementation is first-line to correct anemia and replenish stores 1
  • Parenteral iron reserved for intolerance to oral preparations 1
  • Blood transfusion is NOT indicated—she is hemodynamically stable and transfusion should be reserved for cardiovascular instability 1

Important Caveats

  • While the elevated platelet/MCH ratio can suggest combined B12 and iron deficiency 3, in a 20-year-old woman with likely menstrual blood loss, isolated iron deficiency is far more probable
  • The normal ALT and creatinine exclude liver and kidney disease as contributing factors
  • If iron studies are normal despite microcytosis, consider thalassemia trait (particularly if family history or ethnicity suggest this)
  • Coeliac disease screening with tissue transglutaminase antibody should be considered if iron deficiency is confirmed, as it has ~5% prevalence in IDA patients 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.